{"id":179792,"date":"2026-02-06T06:36:02","date_gmt":"2026-02-06T11:36:02","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=179792"},"modified":"2026-02-06T06:36:04","modified_gmt":"2026-02-06T11:36:04","slug":"krsnaa-diagnostics-q3-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/krsnaa-diagnostics-q3-fy26-earnings-results\/","title":{"rendered":"Krsnaa Diagnostics Q3 FY26 Earnings Results"},"content":{"rendered":"\n<p>Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.<\/p>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Q3 FY26 Earnings Results<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue from Operations:<\/strong> \u20b9174.5 cr, +10.2% YoY vs \u20b9158.3 cr in Q3 FY25, steady growth in diagnostic services revenues. <\/li>\n\n\n\n<li><strong>EBITDA:<\/strong> \u20b947 cr, +24% YoY, <strong>EBITDA margin 30%<\/strong>, reflecting operational leverage from expanded network and efficiency gains.<\/li>\n\n\n\n<li><strong>PAT:<\/strong> \u20b919.4 cr, +50% YoY vs \u20b912.97 cr in Q3 FY25, significant profit growth on higher scale and margins. <\/li>\n\n\n\n<li><strong>EPS:<\/strong> \u20b95.88 per share (normalized; up 48% YoY). <\/li>\n\n\n\n<li><strong>Other key metrics:<\/strong> Total income (incl. other income) \u20b9296 cr reflecting service diversification and ancillary income. <\/li>\n<\/ul>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Management Commentary &amp; Strategic Decisions<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Management highlighted a <strong><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachLive\/0399ad84-9a73-4386-beae-4ff958f86384.pdf\" target=\"_blank\" rel=\"noopener\">healthy uptick in revenue and margins<\/a><\/strong>, attributing performance to <strong>increased patient volumes, expanded diagnostic footprints, and improved asset utilisation<\/strong> across pathology and radiology services. Commentary emphasised disciplined execution of PPP contracts and expansion in Tier-II\/III markets. <\/li>\n\n\n\n<li>Leadership noted <strong>margin expansion driven by operating efficiencies and in-house service integration<\/strong>, underpinning sustainable profit growth. Strategic priorities remain on <strong>network expansion and service quality enhancement<\/strong> to capture growing demand for affordable diagnostics.<\/li>\n<\/ul>\n\n\n\n<div style=\"height:33px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Q2 FY26 Earnings Result<\/strong>s<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue from Operations:<\/strong> \u20b9210.2 cr, +10.1% YoY (vs \u20b9190.9 cr in Q2 FY25). <\/li>\n\n\n\n<li><strong>EBITDA:<\/strong> \u20b959.2 cr, +19.9% YoY; <strong>EBITDA Margin <\/strong>28.7<strong>%<\/strong>, stronger margins on operating scale. <\/li>\n\n\n\n<li><strong>PAT:<\/strong> \u20b923.95 cr, +22.2% YoY; <strong>PAT Margin 11.4%<\/strong>, good bottom-line expansion. <\/li>\n\n\n\n<li><strong>EPS:<\/strong> \u20b97.25 per share. <\/li>\n<\/ul>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Management Commentary Q2<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>In Q2, management cited <strong>solid revenue growth and margin improvement<\/strong>, with <strong>revenue and PAT up double-digits YoY<\/strong>, driven by expanding patient volumes and a broader service network.<\/li>\n\n\n\n<li>Commentary emphasised <strong>disciplined execution and operating leverage<\/strong>, supporting margin expansion even amid competitive pricing and cost headwinds.<\/li>\n<\/ul>\n\n\n\n<p>To view the company\u2019s previous earnings and latest concall transcripts,&nbsp;<a href=\"https:\/\/alphastreet.com\/india\/\">click here<\/a>&nbsp; to visit the Alphastreet India news channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. Q3 FY26 Earnings Results Management Commentary &amp; Strategic Decisions Q2 FY26 Earnings Results Management Commentary Q2 [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,5747],"tags":[8665],"class_list":["post-179792","post","type-post","status-publish","format-standard","hentry","category-infographics","category-healthcare-stocks","tag-diagnostics"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":172307,"url":"https:\/\/alphastreet.com\/india\/krsnaa-diagnostics-q2-fy26-earnings-results\/","url_meta":{"origin":179792,"position":0},"title":"Krsnaa Diagnostics Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"November 11, 2025","format":false,"excerpt":"Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. \u00a0 Q2 FY26 Earnings Results for NSE: KRSNAA (Krsnaa Diagnostics Limited)\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Krsnaa Diagnostics Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Krsnaa-Diagnostics-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Krsnaa-Diagnostics-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Krsnaa-Diagnostics-Q2-FY26-Earnings-Results.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Krsnaa-Diagnostics-Q2-FY26-Earnings-Results.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Krsnaa-Diagnostics-Q2-FY26-Earnings-Results.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Krsnaa-Diagnostics-Q2-FY26-Earnings-Results.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170746,"url":"https:\/\/alphastreet.com\/india\/krsnaa-diagnostics-q1-fy26-earnings-results\/","url_meta":{"origin":179792,"position":1},"title":"Krsnaa Diagnostics Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 28, 2025","format":false,"excerpt":"Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. Presenting below are its Q1 FY26 earnings results. \u00a0 Q1 FY26\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Krsnaa Diagnostics Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/7-14.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/7-14.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/7-14.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/7-14.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/7-14.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/7-14.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":178200,"url":"https:\/\/alphastreet.com\/india\/thyrocare-q3-fy26-earnings-results\/","url_meta":{"origin":179792,"position":2},"title":"Thyrocare Q3 FY26 Earnings Results","author":"Chirag Gupta","date":"January 28, 2026","format":false,"excerpt":"Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. Q3 FY26 Earnings Results Revenue from Operations: Consolidated \u20b9196 cr, +18% YoY vs \u20b9166 cr, total income \u20b9200.51 cr; standalone \u20b9183 cr\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-101.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-101.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-101.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-101.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-101.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-101.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":130869,"url":"https:\/\/alphastreet.com\/india\/krsnaa-diagnostics-ltd-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":179792,"position":3},"title":"Krsnaa Diagnostics Ltd Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 28, 2022","format":false,"excerpt":"https:\/\/youtu.be\/oafWwDciC8w Key highlights from Krsnaa Diagnostics Ltd (KRSNAA) Q4 FY22 Earnings Concall Q&A Highlights: Praveen Sahay of Edelweiss asked that why the other financial assets is jumped up on a YoY basis. Yash Mutha ED said it\u2019s because majority of chunk in other financial assets is mainly FDs of more\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":156418,"url":"https:\/\/alphastreet.com\/india\/krsnaa-diagnostics-ltd-q2fy24-39-fall-in-profits\/","url_meta":{"origin":179792,"position":4},"title":"Krsnaa Diagnostics Ltd Q2FY24; 39% fall in Profits","author":"Hardik Bhandare","date":"November 20, 2023","format":false,"excerpt":"Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. Financial Results: Krsnaa Diagnostics Ltd reported Revenues for Q2FY24 of \u20b9147.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-246.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-246.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-246.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-246.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-246.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-246.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":153292,"url":"https:\/\/alphastreet.com\/india\/krsnaa-diagnostics-ltd-q1fy24-7-rise-in-profits\/","url_meta":{"origin":179792,"position":5},"title":"Krsnaa Diagnostics Ltd Q1FY24; 7% rise in Profits","author":"Hardik Bhandare","date":"August 14, 2023","format":false,"excerpt":"Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. Financial Results: Krsnaa Diagnostics Ltd reported Revenues for Q1FY24 of \u20b9140.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-870.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-870.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-870.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-870.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-870.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-870.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=179792"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179792\/revisions"}],"predecessor-version":[{"id":179793,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179792\/revisions\/179793"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=179792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=179792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=179792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}